Skip to Main Content

Author Details

Michael Gale
Center for Innate Immunity and Immune Disease, University of Washington
1988
333
91
PMIDPaper TitleJournal TitlePublished Year
36894436Programming cytomegalovirus as an HIV vaccine.Trends Immunol2023
37479700Increased interregional virus exchange and nucleotide diversity outline the expansion of chikungunya virus in Brazil.Nat Commun2023
37506197Modulation of type I interferon responses potently inhibits SARS-CoV-2 replication and inflammation in rhesus macaques.Sci Immunol2023
37022164Type I Interferon Orchestrates Demand-Adapted Monopoiesis during Influenza A Virus Infection via STAT1-Mediated Upregulation of Macrophage Colony-Stimulating Factor Receptor Expression.J Virol2023
37317284Expression of Envelope Protein Encoded by Endogenous Retrovirus K102 in Rheumatoid Arthritis Neutrophils.Microorganisms2023
37383986Evaluation of the immunogenicity and efficacy of an rVSV vaccine against Zika virus infection in macaca nemestrina.Front Virol2023
37243216Orthohantavirus Replication in the Context of Innate Immunity.Viruses2023
37074651Assessing Cytoskeletal Destruction During Pyroptosis.Methods Mol Biol2023
37437537Innate immunity and interferon in SARS-CoV-2 infection outcome.Immunity2023
37034611Increased interregional virus exchange and nucleotide diversity outline the expansion of the chikungunya virus ECSA lineage in Brazil.medRxiv2023
37097146COVID-19 Antigen Results Correlate with the Quantity of Replication-Competent SARS-CoV-2 in a Cross-Sectional Study of Ambulatory Adults during the Delta Wave.Microbiol Spectr2023
36961450Cytotoxic T Cells Targeting Spike Glycoprotein Are Associated with Hybrid Immunity to SARS-CoV-2.J Immunol2023
37162358Viral Protein Accumulation of Zika Virus Variants Links with Regulation of Innate Immunity for Differential Control of Viral Replication, Spread, and Response to Interferon.J Virol2023
36851745Dynamics of SARS-CoV-2 VOC Neutralization and Novel mAb Reveal Protection against Omicron.Viruses2023
36913789Duration of viral infectiousness and correlation with symptoms and diagnostic testing in non-hospitalized adults during acute SARS-CoV-2 infection: A longitudinal cohort study.J Clin Virol2023
36713156RIG-I and MDA5 are modulated by bone morphogenetic protein (BMP6) and are essential for restricting Zika virus infection in human Sertoli cells.Front Microbiol2023
36939421A Small Molecule RIG-I Agonist Serves as an Adjuvant to Induce Broad Multifaceted Influenza Virus Vaccine Immunity.J Immunol2023
34560047Recurrent bacterial vaginosis following metronidazole treatment is associated with microbiota richness at diagnosis.Am J Obstet Gynecol2022
35412328Multivalent designed proteins neutralize SARS-CoV-2 variants of concern and confer protection against infection in mice.Sci Transl Med2022
35804422Innate immune regulation in HIV latency models.Retrovirology2022
35413241Imprinted SARS-CoV-2-specific memory lymphocytes define hybrid immunity.Cell2022
36536032Alternative splicing and genetic variation of mhc-e: implications for rhesus cytomegalovirus-based vaccines.Commun Biol2022
36600780Angiopoietin-Like4 Is a Novel Marker of COVID-19 Severity.Crit Care Explor2022
36415465A C57BL/6 Mouse model of SARS-CoV-2 infection recapitulates age- and sex-based differences in human COVID-19 disease and recovery.Res Sq2022
35938988IgM antibodies derived from memory B cells are potent cross-variant neutralizers of SARS-CoV-2.J Exp Med2022
36039098Extended Remdesivir Infusion for Persistent Coronavirus Disease 2019 Infection.Open Forum Infect Dis2022
35932641Replicating RNA platform enables rapid response to the SARS-CoV-2 Omicron variant and elicits enhanced protection in naïve hamsters compared to ancestral vaccine.EBioMedicine2022
36036783Correction: IgM antibodies derived from memory B cells are potent cross-variant neutralizers of SARS-CoV-2.J Exp Med2022
36032965Dynamics of SARS-CoV-2 VOC neutralization and novel mAb reveal protection against Omicron.medRxiv2022
36198789STING-induced regulatory B cells compromise NK function in cancer immunity.Nature2022
35981532Cytomegalovirus-vaccine-induced unconventional T cell priming and control of SIV replication is conserved between primate species.Cell Host Microbe2022
36190406Combinations of Host- and Virus-Targeting Antiviral Drugs Confer Synergistic Suppression of SARS-CoV-2.Microbiol Spectr2022
35191378SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern.Elife2022
35118477T cell response to intact SARS-CoV-2 includes coronavirus cross-reactive and variant-specific components.medRxiv2022
35304593ZIKV can infect human term placentas in the absence of maternal factors.Commun Biol2022
34904460Myelin Protein Zero Immunohistochemistry Is Not a Reliable Marker of Extrinsic Mucosal Innervation in Patients With Hirschsprung Disease.Pediatr Dev Pathol2022
35082782Liver Bacterial Dysbiosis With Non-Tuberculosis Mycobacteria Occurs in SIV-Infected Macaques and Persists During Antiretroviral Therapy.Front Immunol2022
34987112Single-Cell-Based High-Throughput Ig and TCR Repertoire Sequencing Analysis in Rhesus Macaques.J Immunol2022
35194205Biological functions of DEAD/DEAH-box RNA helicases in health and disease.Nat Immunol2022
32341066Innate Immunity in Hepatitis C Virus Infection.Cold Spring Harb Perspect Med2021
33770145The herpesvirus accessory protein γ134.5 facilitates viral replication by disabling mitochondrial translocation of RIG-I.PLoS Pathog2021
33849972SARS-CoV-2 ORF6 Disrupts Bidirectional Nucleocytoplasmic Transport through Interactions with Rae1 and Nup98.mBio2021
33893179Correlation of Regulatory T Cell Numbers with Disease Tolerance upon Virus Infection.Immunohorizons2021
33579750Innate cell microenvironments in lymph nodes shape the generation of T cell responses during type I inflammation.Sci Immunol2021
34931189SARS-CoV2 variant-specific replicating RNA vaccines protect from disease and pathology and reduce viral shedding following challenge with heterologous SARS-CoV2 variants of concern.bioRxiv2021
34250540Corrigendum to: SARS-CoV-2 Serologic Assays in Control and Unknown Populations Demonstrate the Necessity of Virus Neutralization Testing.J Infect Dis2021
34268509Multivalent designed proteins protect against SARS-CoV-2 variants of concern.bioRxiv2021
34342578Endomembrane targeting of human OAS1 p46 augments antiviral activity.Elife2021
34003679The Experts Speak: A New Feature in the JICR.J Interferon Cytokine Res2021
34370798Single-cell transcriptomic analyses of T cells in chronic HCV-infected patients dominated by DAA-induced interferon signaling changes.PLoS Pathog2021
  • 1 - 50 of 333

Recommended Authors

Adam Hage
University of Texas Medical Branch
Career Start Year 2017
Number of shared co-authors 4
David Sachs
Icahn School of Medicine at Mount Sinai
Career Start Year 2013
Number of shared co-authors 2
Maxime Chazal
CNRS UMR9, Institut Pasteur, Universite de Paris Cite
Career Start Year 2012
Number of shared co-authors 3
Shashank Tripathi
Indian Institute of Science
Career Start Year 2011
Number of shared co-authors 6
Craig B Wilen
Yale School of Medicine
Career Start Year 2010
Number of shared co-authors 11
Maria Teresa S??nchez-Aparicio
Icahn School of Medicine at Mount Sinai
Career Start Year 2009
Number of shared co-authors 6
Siyuan Ding
Washington University School of Medicine
Career Start Year 2009
Number of shared co-authors 6
Hans-Heinrich Hoffmann
The Rockefeller University
Career Start Year 2008
Number of shared co-authors 7
Lisa Miorin
Icahn School of Medicine at Mount Sinai
Career Start Year 2008
Number of shared co-authors 8
Priya Luthra
Trudeau Institute
Career Start Year 2007
Number of shared co-authors 2
Mohsan Saeed
Boston University Chobanian and Avedisian School of Medicine
Career Start Year 2007
Number of shared co-authors 5
Colm Atkins
Rutgers University
Career Start Year 2007
Number of shared co-authors 2
Nicholas S Heaton
Duke University School of Medicine
Career Start Year 2006
Number of shared co-authors 8
Jan Rehwinkel
MRC Weatherall Institute of Molecular Medicine, University of Oxford
Career Start Year 2004
Number of shared co-authors 3
Shirit Einav
Stanford University School of Medicine
Career Start Year 2002
Number of shared co-authors 6
Sagi Shapira
Institute for Genomic Medicine, Columbia University
Career Start Year 2002
Number of shared co-authors 4
Thomas E Morrison
University of Colorado Anschutz Medical Campus
Career Start Year 2001
Number of shared co-authors 19
Edward P Browne
University of North Carolina at Chapel Hill
Career Start Year 2000
Number of shared co-authors 4
Victor R DeFilippis
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Career Start Year 2000
Number of shared co-authors 11
Daisy W Leung
Washington University School of Medicine
Career Start Year 1999
Number of shared co-authors 5
Renate K??nig
Paul-Ehrlich-Institut
Career Start Year 1998
Number of shared co-authors 2
Ricardo Rajsbaum
University of Texas Medical Branch
Career Start Year 1998
Number of shared co-authors 6
Sonja M Best
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1998
Number of shared co-authors 21
J??rgen Haas
University of Edinburgh
Career Start Year 1996
Number of shared co-authors 2
Shelly J Robertson
National Institute of Allergy and Infectious Diseases
Career Start Year 1995
Number of shared co-authors 9
Abraham L Brass
University of Massachusetts Medical School
Career Start Year 1995
Number of shared co-authors 6
Sara Cherry
University of Pennsylvania
Career Start Year 1993
Number of shared co-authors 11
Ana Fernandez-Sesma
Icahn School of Medicine at Mount Sinai
Career Start Year 1993
Number of shared co-authors 10
Lucy Thorne
University College London
Career Start Year 1992
Number of shared co-authors 2
Akiko Iwasaki
Yale University
Career Start Year 1990
Number of shared co-authors 11

Collaborators

Michael S Diamond
Washington University School of Medicine
Co-authored papers 34
Richard Green
Center for Innate Immunity and Immune Disease, University of Washington
Co-authored papers 30
Michael G Katze
University of Washington
Co-authored papers 27
Mehul S Suthar
Co-authored papers 26
Courtney Wilkins
Center for Innate Immunity and Immune Disease, University of Washington
Co-authored papers 20
Renee C Ireton
Center for Innate Immunity and Immune Disease, University of Washington
Co-authored papers 17
Jennifer Tisoncik-Go
Center for Innate Immunity and Immune Disease, University of Washington
Co-authored papers 13
Kathleen M Voss
Center for Innate Immunity and Immune Disease, University of Washington
Co-authored papers 12
Ralph S Baric
University of North Carolina
Co-authored papers 10
Martin T Ferris
University of North Carolina.
Co-authored papers 9
Stacy M Horner
Co-authored papers 9
Jean Chang
Center for Innate Immunity and Immune Disease, University of Washington
Co-authored papers 8
Jennifer M Lund
Fred Hutchinson Cancer Research Center
Co-authored papers 8
Eileen Foy
University of California san francisco
Co-authored papers 8
Jessica B Graham
BIO5 Institute, The University of Arizona
Co-authored papers 7
Sunil Thomas
Lankenau Institute for Medical Research
Co-authored papers 7
Jessica L Swarts
Fred Hutchinson Cancer Research Center
Co-authored papers 6
Alexander L Greninger
University of Washington Medical Center
Co-authored papers 6
Fernando Pardo-Manuel de Villena
University of North Carolina
Co-authored papers 6
Aimee Sekine
Center for Innate Immunity and Immune Disease
Co-authored papers 6
Lauren Carter
Co-authored papers 5
Neil P King
Co-authored papers 5
Margaret Juliana McElrath
Co-authored papers 5
Louis J Picker
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Co-authored papers 5
Piper M Treuting
University of Washington
Co-authored papers 5
Collin M Blakely
University of California san francisco
Co-authored papers 4
Jeffrey D Lifson
Frederick National Laboratory
Co-authored papers 4
Mark T Heise
University of North Carolina at Chapel Hill.
Co-authored papers 4
Michael A Mooney
Knight Cancer Institute Oregon Health & Science University Portland Oregon USA.
Co-authored papers 4
Wesley C Van Voorhis
Center for Emerging and Re-emerging Infectious Diseases, University of Washington
Co-authored papers 4
Release 1.2